Oklahoma Insulin Access Program Signed Into Law

Oklahoma Insulin Access Program Signed Into Law

Governor Kevin Stitt has signed legislation creating the new Oklahoma Insulin Access Program, a statewide effort designed to improve insulin affordability and expand access to life-saving diabetes medication.

The new law establishes the Oklahoma Insulin Access Program under the Oklahoma State Department of Health and aims to lower prescription drug costs while encouraging domestic insulin manufacturing.

According to the Oklahoma House of Representatives, the program is expected to benefit roughly 200,000 Oklahomans living with diabetes.

The legislation officially takes effect on November 1, 2026.

Oklahoma Insulin Access Program Targets Lower Costs

The new Oklahoma Insulin Access Program allows the Oklahoma State Department of Health to financially support pharmaceutical manufacturers developing or producing fast-acting biosimilar insulin inside the United States.

State officials say the goal is to increase market competition while helping reduce insulin shortages and high prescription costs.

Participating manufacturers must enter into formal agreements with the state before receiving funding.

According to the legislation, companies receiving support through the Oklahoma Insulin Access Program must also match state funding dollar-for-dollar using non-state funds.

Manufacturers Must Meet Reporting Requirements

The law also includes accountability requirements tied to the Oklahoma Insulin Access Program.

Manufacturers participating in the program will be required to submit annual reports detailing insulin production, development, and distribution efforts.

Lawmakers say the reporting process is intended to ensure transparency and track whether the program successfully improves insulin access for Oklahoma patients.

According to the Oklahoma State Department of Health, biosimilar insulin products can help lower costs by increasing competition within the pharmaceutical marketplace.

Lawmakers Highlight Diabetes Relief

Supporters of the Oklahoma Insulin Access Program say many Oklahoma families continue struggling with rising medication costs.

Legislative leaders backing the bill argued no Oklahoman should be forced to choose between paying household bills and purchasing life-saving insulin.

The legislation also reflects broader national conversations surrounding prescription drug affordability and domestic pharmaceutical manufacturing.

Additional information regarding the Oklahoma Insulin Access Program is expected from the Oklahoma State Department of Health before the law officially takes effect later this year.

🔴 MORE RADIO NEWS